Nov 8, 2026 · Science & Research Daily Digest
Science, space, biomedicine, and climate research highlights compiled for November 8, 2026, with summaries, links, and commentary.
I. Space & Deep Space
1. NASA advances Moon Base: CLPS 2 up to ~$10B over 10 years, nuclear PROMISE rover eyed for late 2028 (lunar infrastructure)
Summary:
At Kennedy Space Center’s MAX POWER event, NASA announced a suite of Moon Base investments. Eight companies—Blue Origin, Firefly Aerospace, Intuitive Machines, ispace-U.S., Lockheed Martin Space, Northrop Grumman Space Systems, SpaceX, and Voyager Technologies—were selected for CLPS 2, a 10-year multiple-award IDIQ contract with a combined maximum value of about $10 billion for delivering science, technology, and infrastructure payloads. NASA is also moving ahead with PROMISE, a six-wheeled nuclear-powered polar rover that JPL will build largely from Curiosity/Perseverance spares and test hardware to drill ~1 m into south-polar regolith, assess ice and resources, and target a late-2028 launch with an ~18-month mission. Blue Origin received a ~$94 million base contract (plus a ~$140 million performance option) to land PROMISE with a Mark 1 lander.
Links:
Commentary:
Moon Base is shifting from concept art to a contest over who can put ton-class cargo on the south pole—nuclear power is the ticket for long lunar nights and permanently shadowed regions.
2. NASA opens a new astronaut class and a $1 million Moon Base Student Challenge (workforce & STEM)
Summary:
On November 8, NASA opened applications for its next astronaut class—deadline December 3, with final selection expected in late 2027—seeking explorers who could live and work at a lunar base and help prepare crewed Mars missions; the agency last opened applications in 2024. The same day it launched a $1 million Moon Base Student Challenge for U.S. high-school and post-secondary teams across six tracks: power generation and storage, construction, life support, surface mobility, communications, and astronaut safety. Registration runs through the NASA STEM Gateway until January 25, 2027.
Links:
- The Guardian — NASA seeks next generation of moon astronauts
- NASA — $1 million Moon Base Student Challenge
Commentary:
After the hardware contracts come the scarcest asset—people who can work through a polar lunar night—so recruiting and student challenges extend the base from procurement into the talent pipeline.
II. Biomedicine & Health
3. MIT: lipid nanoparticles reprogram NK cells in vivo, clearing tumors and reversing liver damage in mice (in vivo cell therapy)
Summary:
An MIT team led by Daniel Anderson reports in Nature Biotechnology ligand-directed lipid nanoparticles (NtLNPs) that deliver CAR-encoding mRNA to natural killer cells, generating CAR NK cells inside the body without apheresis or ex vivo manufacturing. In mice, targeted NK transfection reached ~80%; in aggressive melanoma, three of five treated animals achieved complete remission; in a humanized T-cell lymphoma model, tumors were eradicated after five injections; and in autoimmune hepatitis, autoreactive T cells were cleared with healing of liver damage. ScienceDaily amplified the MIT-sourced advance on November 8; all results remain preclinical, with human safety and efficacy unproven.
Links:
- MIT News — Reprogrammed NK cells target cancer and autoimmunity
- Nature Biotechnology — In vivo engineering of CAR NK cells with ligand-directed LNPs
Commentary:
Moving the CAR factory into the bloodstream—if it translates, cell therapy’s bottleneck shifts from “who can afford manufacturing” to “who can control in-body delivery.”
4. Cambridge team: AI-designed broad-spectrum bird-flu vaccine fully protects mice and ferrets (vaccines)
Summary:
Researchers at the University of Cambridge’s Laboratory of Viral Zoonotics and spin-out DIOSynVax used global avian-influenza sequence surveillance and AI tools to design “super-antigens” capturing shared features across H5Nx diversity, yielding candidate DVX-panH5Nx. In animal challenges with genetically diverse variants that have caused human infections and pose pandemic risk, vaccinated mice and ferrets all survived, versus roughly half survival with existing stockpiled bird-flu vaccines. The study appears in Cell Reports Medicine; Xinhua reported the advance from London on November 8, and human trials are the next planned step.
Links:
- University of Cambridge — AI-developed vaccines against viruses
- Xinhua — AI-assisted bird-flu vaccine advances in animal studies
Commentary:
Pandemic stockpiles win when a shot still works against variants that have not yet emerged—covering a lineage beats endlessly chasing the latest isolate.
5. ETH Zurich: wireless electrocatalytic implant ECHO controls glucose without drugs in diabetic mice (metabolic devices)
Summary:
Martin Fussenegger’s group at ETH Zurich reports in Science an implantable, wirelessly powered electrocatalytic closed-loop system (ECHO): platinum-decorated gold nanoclusters in graphite felt oxidize excess glucose to renally cleared gluconate. In obese type-2 diabetic mice, low-power activation (~0.75 V, 10 mA) restored euglycemia within about an hour; repeated daily treatment held control for ~6 weeks without detectable hypoglycemia, shifting metabolism toward stored fat and lowering body weight and triglycerides. Coupling to a commercial CGM enabled autonomous on/off control; human-scale clearance, durability, and safety remain untested.
Links:
- Science — Wireless electrocatalytic closed-loop system for diabesity
- ETH Zurich — Electronic implant lowers blood sugar
Commentary:
Instead of hormones that hide sugar, the device turns sugar into a flushable molecule—if it scales to human blood volume, lifelong drug dosing faces a genuine hardware rival.
6. FDA formally investigates malignancy risk with Zolgensma: vector DNA integration activating GLI1 (gene-therapy safety)
Summary:
On November 6 the FDA posted that postmarketing reports include malignancies after Zolgensma (onasemnogene abeparvovec) for spinal muscular atrophy, with evidence of product-related insertional oncogenesis involving the GLI1 oncogene—molecular analysis in at least two tumors showed AAV vector DNA integrated upstream of or within GLI1 and potentially driving it. The agency says the same vector/construct risk applies to intrathecal Itvisma (no neoplasia cases reported yet), that benefits still outweigh risks for approved uses, and that it is reviewing labeling and long-term follow-up while urging tumor monitoring. Weekend science and health coverage continued to track the regulatory shift.
Links:
- FDA — Investigating malignancy risk linked to Zolgensma
- IBTimes — FDA probes Novartis SMA gene therapies for cancer risk
Commentary:
A once-“theoretical” integration risk is now described with a confirmed mechanism—long-term AAV surveillance is no longer a footnote on the label.
7. FDA grants accelerated approval to Rybrevant Faspro for recurrent/metastatic HNSCC (oncology)
Summary:
On November 5 the FDA granted accelerated approval to Johnson & Johnson’s amivantamab plus hyaluronidase (Rybrevant Faspro) for recurrent or metastatic head and neck squamous cell carcinoma after platinum chemotherapy and anti–PD-(L)1 therapy (excluding HPV-related oropharyngeal disease). Based on Ib/II OrigAMI-4 data, confirmed ORR was about 42% (CR ~15%), with ~56% of responders lasting ≥6 months—versus typical later-line ORRs often ≤20%. Full approval hinges on confirmatory first-line Phase 3 OrigAMI-5; it is a rare new option in a long-underserved setting and brings EGFR×MET dual targeting into head and neck cancer.
Links:
- FDA — Oncology approval notifications (amivantamab-hyaluronidase)
- Devdiscourse / Reuters Health — FDA grants J&J accelerated approval for head and neck cancer
Commentary:
Later-line head and neck cancer has had few new drugs for a decade—a subcutaneous dual-targeted antibody finally adds a mechanistic option where choices were scarce.
III. Climate, Energy & Environment
8. Zhejiang/PolyU-led team: balancing charge losses between neighboring grains extends perovskite cell lifetime (photovoltaics)
Summary:
Researchers from Zhejiang University, The Hong Kong Polytechnic University, CUHK, the Max Planck Institute for Sustainable Materials, and partners report that mixed-facet perovskite films suffer asymmetric defects and recombination at (100)/(111) grain boundaries (~300 vs ~800 cm/s), driving hole accumulation on the (111) side and accelerating light-induced aging. Treating boundaries with 3-fluorophenylethylammonium bromide (m-F-PEABr) balanced recombination (~300 and ~320 cm/s), lifted small-area efficiency from ~25.19% to 26.55%, and extended time to 90% of initial efficiency under 1-sun MPP in nitrogen from ~800 to ~2,200 hours (~270 to ~1,250 hours at 85°C). Industry coverage dated the advance November 8, 2026.
Links:
Commentary:
Stability is not only how tough each grain is, but how neighbors steal charge from each other—grain-boundary charge accounting is now near the last gate to commercialization.
9. Satellites see greener-bluer waters near the Great Pacific Garbage Patch: microplastics may shift ocean color (marine pollution)
Summary:
Shea Cheatham and colleagues at the University of Bergen report in Communications Earth & Environment that three 2002–2022 northeast Pacific ocean-color records show significant blue and green brightening in and around the Great Pacific Garbage Patch, yielding a more cyan appearance. Radiative-transfer and >50,000 Monte Carlo simulations find cyan brightening roughly four times more likely with suspended microplastics (~13%) than with natural factors alone (~3%), and detectable near ~5 mg/m³. The authors caution that datasets disagree on magnitudes and that direct in situ microplastic measurements are still required; Chinese media highlighted the findings on November 8.
Links:
- Communications Earth & Environment — Ocean color changing near the Great Pacific Garbage Patch
- China News Service — Bluer-greener Pacific waters may track microplastics
Commentary:
When pollution rewrites the satellite palette, monitoring moves from nets toward orbital diagnostics—but ground truth in the patch is still the missing mile.
10. CityU AI emulator: Antarctic mass loss this century looks largely locked in; high emissions up to 25.4 cm sea-level contribution (ice sheets)
Summary:
Yucheng Lin of City University of Hong Kong and collaborators use a physics-informed machine-learning emulator of ISMIP6 ice-sheet simulations, Bayesian-calibrated to 2002–2021 satellite gravimetry, in Nature Geoscience. Even under aggressive emissions cuts, continued twenty-first-century Antarctic mass loss remains very likely (posterior probability ~≥0.92); under very high emissions, observation-consistent projections reach up to ~25.4 cm of sea-level rise from Antarctica alone by 2100 (95th percentile; median ~15.7 cm). Key uncertainties include ice-shelf melt parameterization, basal sliding laws, and driving climate models; Hong Kong coverage on November 8 stressed that cutting emissions still sharply reduces melt severity.
Links:
- CityUHK Scholars — Committed Antarctic Ice Sheet mass loss by 2100
- Wen Wei Po — CityU AI model: Antarctic melt may add 25.4 cm sea level
Commentary:
“Locked-in this century” is not “emissions no longer matter”—those extra centimetres on the upper tail are still coastal adaptation budgets for tens of millions of people.
IV. Fundamental Research
11. European XFEL: 300-attosecond X-ray pulses focused to ~180×330 nm (ultrafast science)
Summary:
A team at the European XFEL reports record-intensity ultrashort X-ray flashes lasting about 300 attoseconds and focused into a spot roughly 180×330 nanometers—packing extreme power into a cross-section far smaller than a human hair. Experiments were performed in April 2026 and published in Optica, with ScienceDaily circulating the result in early November. Combining attosecond duration with extreme intensity could let researchers observe electron motion in atoms and molecules before the probe strongly perturbs the sample, and may eventually help control ultrafast chemical steps.
Links:
Commentary:
Watching an electron “turn” requires stuffing light into a box that is both short and tiny—attosecond sources are turning chemical dynamics into a film that can be shot.
12. Ultracold three-component lithium system: competing magnetic correlations in an optical lattice (quantum simulation)
Summary:
An international team trapped lithium-6 atoms in an optical lattice using three internal quantum states as fermionic components, independently tuning the three pairwise interactions. The experiment revealed coexisting ferromagnetic and antiferromagnetic correlations depending on interaction strengths, plus measurements of triply occupied sites that matched numerical work by collaborators including Rice University. The platform aims at controllable analogs of hard problems from high-Tc superconductivity to three-color quark dynamics; three-body losses and heating still limit colder phases. The study appears in Science and was covered by science media on November 8.
Links:
Commentary:
Moving beyond two-component Hubbard physics—what many-body science often lacks is not compute, but a third knob the lab can actually turn.
Today's Summary
- NASA pushed lunar south-pole infrastructure into bid-ready territory with CLPS 2 and nuclear PROMISE, while opening astronaut and student pipelines the same weekend.
- In vivo CAR NK reprogramming, AI-designed broad bird-flu antigens, and a drug-free electrocatalytic glucose implant show biomedicine moving cell factories, antigen design, and metabolic control into the body and the algorithm.
- FDA’s formal Zolgensma insertional-oncogenesis probe marks a shift for AAV gene therapy from theoretical risk language to mechanism-level scrutiny.
- Perovskite grain-boundary engineering, a possible satellite fingerprint of Pacific microplastics, and “committed” Antarctic mass loss underline how energy and climate weak points are still amplifying.
Daily Framing:
A dual track of lunar infrastructure contracts and in-body reprogramming—south-polar rover deals signed above, while immunity, vaccines, and glucose control are rewritten as deliverable, computable systems below.
This digest is compiled from real-time search results and is for reference only.